Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage

Anesthesiology

Volumn 110, Issue 3, 2009, Pages 603-610

  Thiele, Robert H ^a   Pouratian, Nader ^a   Zuo, Zhiyi ^a   Scalzo, David C ^a   Dobbs, Heather A ^a   Dumont, Aaron S ^a   Kassell, Neal F ^b   Nemergut, Edward C ^a,b  

^a Department of Anesthesiology ^*  (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ARTERY ANEURYSM; CLINICAL PROTOCOL; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; INSULIN INFUSION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUBARACHNOID HEMORRHAGE; BLOOD; COMPARATIVE STUDY; METABOLISM; RETROSPECTIVE STUDY;

BLOOD GLUCOSE; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE;

EID: 62349096662     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318198006a     Document Type: Article

References (47)

1. Corstjens AM, van der Horst ICC, Zijistra JG, Groeneveld ABJ, Zijistra F, Tulleken JE, Ligtenberg JJM: Hyperglycaemia in critically ill patients: Marker or mediator of mortality? Critical Care (London, England) 2006; 10:216
2. Malmberg K, Norhammar A, Wedel H, Ryden L: Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99:2626-32
3. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL, Investigators I: Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40:1748-54
4. Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355:773-8
5. Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, Timmis AD: A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003; 89:512-6
6. Malmberg K: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997; 314:1512-5
7. SalaJ, Masia R, Gonzalez de Molina FJ, Fernandez-Real JM, Gil M, Bosch D, Ricart W, Senti M, Marrugat J, Investigators R: Short-term mortality ofmyocardial infarction patients with diabetes or hyperglycaemia during admission. J Epidemiol Community Health 2002; 56:707-12
8. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WR: Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59:67-71
9. Yendamuri S, Fulda GJ, Tinkoff GH: Admission hyperglycemia as a prognostic indicator in trauma. Journal of Trauma-Injury Infection & Critical Care 2003; 55:33-8
10. Sperry JL, Frankel HL, Vanek SL, Nathens AB, Moore EE, Maier RV, Minei JP: Early hyperglycemia predicts multiple organ failure and mortality but not infection. J Trauma 2007; 63:487-93; discussion 493-4
11. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr: Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003; 75: 1392-9
12. Guvener M, Pasaoglu I, Demircin M, Oc M: Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 2002; 49:531-7
13. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS: The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22:607-12
14. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL: Perioperative glyce-mic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999; 22:1408-14
15. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hypergly-cemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001; 32:2426-32
16. Kagansky N, Levy S, KnoblerH: The role ofhyperglycemiainacute stroke. Arch Neurol 2001; 58:1209-12
17. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM: Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52:20-8
18. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE: Group Nr-PSS: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59:669-74
19. Jeremitsky E, Omert LA, Dunham CM, Wilberger J, Rodriguez A: The impact of hyperglycemia on patients with severe brain injury. J Trauma 2005; 58:47-50
20. Lanzino G, Kassell NF, Germanson T, Truskowski L, Alves W: Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 1993; 79:885-91
21. Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA: Global cerebral edema after subarachnoid hemorrhage: Frequency, predictors, and impact on outcome. Stroke 2002; 33:1225-32
22. Claassen J, Vu A, Kreiter KT, Kowalski RG, Du EY, Ostapkovich N, Fitzsimmons B-FM, Connolly ES, Mayer SA: Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med 2004; 32: 832-8
23. Juvela S, Siironen J, Kuhmonen J: Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. JNeurosurg 2005; 102:998-1003
24. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-67
25. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network S: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-39
26. Devos P, Preiser J-C, Melot C: Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycemia: Final results of the Glucontrol Study. Intensive Care Med 2007; 33:189
27. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-61
28. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ: Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005; 64:1348-53
29. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, Bonnet N, Riou B, Coriat P: Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 2005; 103:687-94
30. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, Williams BA, Schrader LM, Rizza RA, McMahon MM: Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005; 80:862-6
31. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM: Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: A randomized trial. Ann Intern Med 2007; 146: 233-43
32. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G: The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: A randomized prospective pilot trial. J Neurosurg Anesthesiol 2007; 19:156-60
33. Lind L, Lithell H: Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival. Clin Intensive Care 1994; 5:100-5
34. Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-7
35. Soylemez Wiener R, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008; 300:933-44
36. Vespa P, Boonyaputthikul R, McArthur DL, Miller C, Etchepare M, Bergs-neider M, Glenn T, Martin N, Hovda D: Intensive insulin therapy reduces micro-dialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med 2006; 34:850-6
37. Kumagai AK, Kang YS, Boado RJ, Pardridge WM: Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 1995; 44:1399-404
38. Boado RJ, Pardridge WM: Glucose deprivation causes posttranscriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization. J Neurochem 1993; 60:2290-6
39. Boado RJ, Pardridge WM: Glucose deprivation and hypoxia increase the expression of the GLUT1 glucose transporter via a specific mRNA cis-acting regulatory element. J Neurochem 2002; 80:552-4
40. Cornford EM, Hyman S, Cornford ME, Clare-Salzler M: Down-regulation of blood-brain glucose transport in the hyperglycemic nonobese diabetic mouse. Neurochem Res 1995; 20:869-73
41. Simpson IA, Appel NM, Hokari M, Oki J, Holman GD, Maher F, Koehler-Stec EM, Vannucci SJ, Smith QR: Blood-brain barrier glucose transporter: effects of hypo-and hyperglycemia revisited. J Neurochem 1999; 72:238-47
42. Preiser J-C: Restoring normoglycemia: Not so harmless. Critical Care (London, England) 2008; 12:116
43. Wilson M, Weinreb J, Hoo GWS: Intensive insulin therapy in critical care: A review of 12 protocols. Diabetes Care 2007; 30:1005-11
44. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471-8
45. Bode BW, Braithwaite SS, Steed RD, Davidson PC: Intravenous insulin infusion therapy: Indications, methods, and transition to subcutaneous insulin therapy. Endocrine Practice 2004; 10 Suppl 2:71-80
46. Egi M, Bellomo R, Stachowski E, French CJ, Hart G: Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105:244-52
47. Molyneux AJ, Kerr RSC, Yu L-M, Clarke M, Sneade M, Yarnold JA, Sander-cock P: International Subarachnoid Aneurysm Trial Collaborative G International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascu-lar coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005; 366:809-17